Clin2
NCT07752472Possibly a fitNot yet recruiting

Study of PSTC100 in healthy adults

Healthy Adult Subjects

This study tests a new medicine called PSTC100 in healthy adults to see if it is safe and how the body handles it. It is a Phase 1 trial, which means the medicine is still early in testing, and your participation could help find out if it might help people with certain conditions later.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
70 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You must be between 18 and 55 years old.
  • Your body mass index (BMI) should be between 18 and 32.
  • You must be in good health with no major medical conditions.
  • If you are female, you must not be pregnant or breastfeeding, and must agree to use contraception.
  • You must not have taken prescription or over-the-counter medications (except vitamins) in the last 14 days.
  • You must not have donated blood in the last month.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07702279Not yet recruiting· Phase 1
Testing PSTB100 in healthy volunteers

This trial tests a new drug called PSTB100 in healthy people to see how safe it is and how the body processes it. If you are generally healthy and meet the age and weight requirements, you may be able to join.

Brisbane, Queensland
NCT06635226Recruiting· Phase 1
Safety study of ID110521156 in healthy adults

This study tests a new investigational drug called ID110521156 in healthy adults. The goal is to see if the drug is safe and how the body processes it. It may be for people who are overweight or obese.

Seoul
NCT07640438Recruiting· Phase 1
Safety Study of New Drug in Healthy Adults

This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.

Hangzhou, Zhejiang
NCT07658638Recruiting· Phase 1
Safety study of TESP-0401 in healthy volunteers

This study tests a new oral medication, TESP-0401, in healthy volunteers to check its safety, how the body processes it, and any side effects. It is a first-in-human trial, so participants help determine if the drug is safe enough for future studies.

Charlestown, Suite 301, 99 Pacific Highway,NSW
NCT07235163Recruiting· Phase 1
Testing a new medicine in healthy adults

This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.

Brussels, Bruxelles-capitale, Région de
NCT06867796Not yet recruiting· Phase 1
Safety study of TL-001 in healthy adults

This trial tests a new drug, TL-001, in healthy volunteers to see if it is safe and how the body processes it. You may join if you are a healthy adult between 18 and 55.

Hear when a new Healthy Adult Subjects trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.